Benefit of Adjuvant Chemotherapy in T1 N0 Triple Negative Breast Cancer Stratified by Tumor Size

被引：0
|
作者：
Fasano, G. A. [1 ]
Bayard, S. [1 ]
Chen, Y. [2 ]
Davis, M. [1 ]
Varella, L. [1 ]
Cigler, T. [1 ]
Simmons, R. [1 ]
Swistel, A. [1 ]
Marti, J. [1 ]
Ng, J. [1 ]
Brandmeier, A. [1 ]
Formenti, S. [1 ]
Newman, L. [1 ]
机构：
[1] Weill Cornell Med, Breast Surg, New York, NY USA
[2] Henry Ford Hlth Syst, Detroit, MI USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P47
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] T1 N0 Triple Negative Breast Cancer: A Bad Actor
    Livingston, Robert
    [J]. BREAST JOURNAL, 2009, 15 (05): : 451 - 453
  • [2] Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer
    Zhai, Zhen
    Zheng, Yi
    Yao, Jia
    Liu, Yu
    Ruan, Jian
    Deng, Yujiao
    Zhou, Linghui
    Zhao, Peng
    Yang, Si
    Hu, Jingjing
    We, Bajin
    Wu, Ying
    Zhang, Dai
    Kang, Huafeng
    Dai, Zhijun
    [J]. JAMA NETWORK OPEN, 2020, 3 (11)
  • [3] Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysis
    Wu, Chenghui
    Huang, Ou
    Wu, Jiayi
    Shen, Kunwei
    Chen, Xiaosong
    Zhu, Siji
    [J]. GLAND SURGERY, 2023, 12 (10) : 1375 - 1386
  • [4] Is there a survival benefit with adjuvant chemotherapy for patients with stage I (T1N0) triple negative breast cancer?
    Luu, T. H.
    Lau, S.
    Nelson, R.
    Ottochian, M.
    Garcia, A.
    Somlo, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy
    Kaplan, Henry G.
    Malmgren, Judith A.
    Atwood, Mary
    [J]. BREAST JOURNAL, 2009, 15 (05): : 454 - 460
  • [6] Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer
    Ren, Yi-Xing
    Hao, Shuang
    Jin, Xi
    Ye, Fu-Gui
    Gong, Yue
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    [J]. BREAST, 2019, 43 : 97 - 104
  • [7] T1N0 triple negative breast cancer: adjuvant chemotherapy treatment and risk of recurrence
    Kaplan, H. H.
    Malmgren, J. A.
    Atwood, M. K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S149 - S150
  • [8] Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
    Chandler S. Cortina
    Jan Irene Lloren
    Christine Rogers
    Morgan K. Johnson
    Adrienne N. Cobb
    Chiang-Ching Huang
    Amanda L. Kong
    Puneet Singh
    Mediget Teshome
    [J]. Annals of Surgical Oncology, 2024, 31 : 3128 - 3140
  • [9] Evaluation of survival outcome of adjuvant chemoradiotherapy compared to other treatment modalities stratified by tumor size in T1N0M0 triple-negative breast cancer
    Ellaithy, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S152 - S152
  • [10] Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?
    Akdag, Goncagul
    Isik, Deniz
    Dogan, Akif
    Yildirim, Sedat
    Kinikoglu, Oguzcan
    Topal, Alper
    Oksuz, Sila
    Turkoglu, Ezgi
    Surmeli, Heves
    Basoglu, Tugba
    Sever, Ozlem Nuray
    Odabas, Hatice
    Yildirim, Mahmut Emre
    Turan, Nedim
    [J]. MEDICINA-LITHUANIA, 2024, 60 (08):
12345